CLINICAL_TRIALS
trial_result
· 2023-08-29
Clinical Trial Update: Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Summary
Phase 2 trial update for PXL065 in nonalcoholic steatohepatitis (NASH) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Poxel SA | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-08-29